In the framework of an increasingly strengthened alliance, Syngenta will begin to distribute the biological seed treatment fungicide developed by Rizobacter

As of this winter cereal season, Syngenta will include in its seed treatment products portfolio a biofungicide developed by Rizobacter and the National Institute of Agricultural Technology (INTA).

This biofungicide is a seed treatment formulation based on the Trichoderma Harzianum (Rizoderma) fungus, which has proven effective to control all seed and soil diseases that affect germination and initial development in wheat crops. Currently, it is also registered in the National Health Service and Food Quality (SENASA) for soybean and rice, and will soon be approved for barley and winter legumes, such as pea and chickpea. Because it is a biological fungicide, it promotes new mechanisms of action that seek to reduce the risks of disease tolerance and achieve a greater persistence of control. At the same time, it offers new, more sustainable and environmentally friendly tools for the end user.

Although Syngenta Argentina will take the first step in commercializing this new concept of seed protection, the expansion and growth potential is considerably higher, since it includes markets such as Europe, where the demand for biological inputs is increasing. As a reference, in Argentina alone, this technology has had an adoption rate greater than 120% year after year, and it has covered over one million hectares of wheat in the last three years.

With this new agreement, Syngenta and Rizobacter renew their mutual trust to continue leading the main crops seed treatment market together. By adding this new strategy for sustainable management that is highly efficient for crop protection, both companies guarantee the grower a wide range of technologies to achieve maximum emergence security and high yields for their crops.